Surgical Versus Conservative Treatment of Weber B1 Fracture: Functional Outcome Using Gait Analysis
WEBER
1 other identifier
observational
29
1 country
1
Brief Summary
The decision whether to operate an ankle fracture or not is often highly dependent on the surgeon's individual judgment. There is consensus that non-displaced Weber A-type fractures rarely require operative treatment, and that Weber C-type or grossly displaced fractures are unstable and therefore require surgery. The decision for appropriate treatment is less clear for minimally displaced Weber B-type ankle fractures, and especially Weber B1 fractures are treated either surgically or conservatively at our clinic. Conservative management of ankle fractures generally comprises immobilisation in a below-knee VacoPed or cast for six weeks to stabilise the fracture and allow osseous and soft tissue healing. Surgical treatment involves the reduction (if displaced) of the fractured fragments and fixation using various devices such as metal plates, screws, or intramedullary rods. While patients show changes in plantar pressure distribution during gait 18 months after surgical treatment of ankle fractures, to date the functional outcome regarding ankle joint mechanics during daily activities are unknown. Understanding gait function is important because compromised function may not only limit a persons daily activities but also may lead to secondary conditions such as osteoarthritis at the ankle or at adjacent joints. The primary objective is:
- To compare differences in hindfoot and forefoot kinematics between level and uphill treadmill walking in relation to passive range of motion The secondary objectives are:
- To compare ankle biomechanics during overground walking and level and uphill treadmill walking between patients with Weber B1 fracture treated either surgically or conservatively and healthy control persons.
- To determine the relationship between passive ankle range of motion, lower leg muscle strength and dynamic ankle range of motion.
- To determine the relationship between lower leg muscle strength and balance.
- To determine the relationship between dynamic range of motion and the Foot and Ankle Outcome Score.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2018
CompletedFirst Submitted
Initial submission to the registry
May 15, 2018
CompletedFirst Posted
Study publicly available on registry
May 29, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2020
CompletedMarch 19, 2024
March 1, 2024
2 years
May 15, 2018
March 18, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
3D hindfoot and forefoot range of motion during level and uphill walking
assessed in degrees as max plantarflexion to max dorsiflexion of the ankle using marker and camera based motion capture
Baseline
Secondary Outcomes (8)
single leg balance
Baseline
ankle power
Baseline
Isokinetic strength in plantarflexion, dorsiflexion, inversion, and eversion
Baseline
Lower leg muscle activation
Baseline
clinical outcome
Baseline
- +3 more secondary outcomes
Study Arms (3)
Control group
age and sex matched healthy control persons
Surgery
patients with ankle fracture treated surgically
Conservative treatment
patients with ankle fracture treated conservatively
Interventions
Eligibility Criteria
20 patients with Weber B1 treated surgically; 20 patients with Weber B1 treated conservatively; 20 age and sex matched healthy control persons
You may qualify if:
- Age ≥ 18 years
- Surgical or conservative treatment after lateral malleolar fracture
- ≥12 months follow-up
You may not qualify if:
- Neuromuscular disorders affecting gait
- Additional pathologies that influence the mobility of the ankle joint
- Bilateral trauma at presentation
- Persistent use of walking aids
- Inability to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Basel
Basel, Canton of Basel-City, 4031, Switzerland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Annegret Mündermann, PhD
University Hospital, Basel, Switzerland
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 15, 2018
First Posted
May 29, 2018
Study Start
May 1, 2018
Primary Completion
April 30, 2020
Study Completion
April 30, 2020
Last Updated
March 19, 2024
Record last verified: 2024-03